İlgar, T. Et Al. 2023. Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991). VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3 , 108-113.

İlgar, T., Ataman Hatipoğlu, Ç., Bulut, C., Altun Demircan, Ş., & Kınıklı, S., (2023). Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991). VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, 108-113.

İlgar, TUBA Et Al. "Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991)," VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, 108-113, 2023

İlgar, TUBA Et Al. "Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991)." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, pp.108-113, 2023

İlgar, T. Et Al. (2023) . "Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991)." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, pp.108-113.

@article{article, author={TUBA İLGAR Et Al. }, title={Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991)}, journal={VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL}, year=2023, pages={108-113} }